Literature DB >> 2015163

Prednisolone concentrations in cerebrospinal fluid after different prednisolone prodrugs.

M Bührer1, F J Frey, B M Frey.   

Abstract

The concentration-time curves of prednisolone in cerebrospinal fluid (CSF) and plasma were measured following an equimolar i.v. bolus dose of prednisolone phosphate (five patients) and prednisolone phthalate (four patients). Independent of the prodrug administered, the value of the AUC (0.360 min) in CSF was more than three times lower than the corresponding value in plasma. The AUCs of unbound prednisolone in plasma were higher after prednisolone phosphate, than after prednisolone phthalate (68.1 +/- 15.7 vs 19.0 +/- 5.2 micrograms ml-1 min, P less than 0.001). Similarly, the AUCs of prednisolone were higher in the CSF after prednisolone phosphate, than after prednisolone phthalate (17.6 +/- 2.8 vs 3.3 +/- 1.0 micrograms ml-1 min, P less than 0.0001). The results indicate that the concentrations of prednisolone in CSF are much lower than the unbound concentrations in plasma and that therapeutic inequivalence should be expected when the two prodrugs are given in equimolar doses.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 2015163      PMCID: PMC1368423          DOI: 10.1111/j.1365-2125.1991.tb03868.x

Source DB:  PubMed          Journal:  Br J Clin Pharmacol        ISSN: 0306-5251            Impact factor:   4.335


  13 in total

1.  Use of dexamethasone in the treatment of cerebral edema resulting from brain tumors and brain surgery.

Authors:  J H GALICICH; L A FRENCH
Journal:  Am Pract Dig Treat       Date:  1961-03

2.  The cerebrospinal fluid and the extracellular fluid of the brain. Introductory remarks.

Authors:  E A Bering
Journal:  Fed Proc       Date:  1974-09

3.  Errors in interpretation of data from equilibrium dialysis protein binding experiments.

Authors:  H L Behm; J G Wagner
Journal:  Res Commun Chem Pathol Pharmacol       Date:  1979-10

4.  High dose glucocorticoids in the management of severe head injury.

Authors:  S L Giannotta; M H Weiss; M L Apuzzo; E Martin
Journal:  Neurosurgery       Date:  1984-10       Impact factor: 4.654

Review 5.  Problems of delivery of drugs to the brain.

Authors:  N Bodor; M E Brewster
Journal:  Pharmacol Ther       Date:  1982       Impact factor: 12.310

6.  Liquid-chromatographic measurement of endogenous and exogenous glucocorticoids in plasma.

Authors:  F J Frey; B M Frey; L Z Benet
Journal:  Clin Chem       Date:  1979-11       Impact factor: 8.327

7.  Prednisolone clearance at steady state in dogs.

Authors:  F J Frey; B M Frey; A Greither; L Z Benet
Journal:  J Pharmacol Exp Ther       Date:  1980-11       Impact factor: 4.030

8.  Steroids and head trauma.

Authors:  W J Molofsky
Journal:  Neurosurgery       Date:  1984-09       Impact factor: 4.654

9.  Urinary 6 beta-hydroxyprednisolone excretion indicates enhanced prednisolone catabolism.

Authors:  F J Frey; B M Frey
Journal:  J Lab Clin Med       Date:  1983-04

10.  Pharmacokinetics of 3 prednisolone prodrugs. Evidence of therapeutic inequivalence in renal transplant patients with rejection.

Authors:  B M Frey; M Seeberger; F J Frey
Journal:  Transplantation       Date:  1985-03       Impact factor: 4.939

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.